Jia et al. used Liensinine to intervene in Ang II‐induced hypertension mice and found that Liensinine could improve the vascular remodeling of mice's abdominal aorta by inhibiting MAPK/TGF‐β1/Smad2/3 signaling pathway. This evidence concerns the gene SMAD2 and hypertensive disorder.